Frontlight ResearchEarly access
Trial site
Hacettepe Universite Hastaneleri
- 11running trials
- 2closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Metastatic breast cancer3 trials
- Obesity2 trials
- Type 2 diabetes2 trials
- Childhood cancers1 trial
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Crohn's disease1 trial
- Dermatomyositis and polymyositis (myositis)1 trial
- Heart failure1 trial
- Neuroblastoma1 trial
- Pancreatic cancer1 trial
- and 4 more
- Phase
- Phase 39 trials
- Phase 23 trials
- Phase 2/31 trial
- Status
- Recruiting5 trials
- Active, not recruiting4 trials
- Completed2 trials
- Not yet recruiting2 trials
- Lead sponsor
- Pfizer5 trials
- Eli Lilly and Company4 trials
- Bristol-Myers Squibb2 trials
- Carrick Therapeutics Limited1 trial
- Mirati Therapeutics Inc.1 trial
Running trials
Not yet recruiting
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Metastatic breast cancer1 recruiting
- Obesity1 recruiting
- Type 2 diabetes1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026